EfruxiferminA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Sponsor:

Akero Therapeutics, Inc

Code:

NCT06528314

Conditions

NASH - Nonalcoholic Steatohepatitis

MASH - Metabolic Dysfunction-Associated Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Efruxifermin

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-20. This information was provided to ClinicalTrials.gov by Akero Therapeutics, Inc on 2026-08-19.